NeuroOne Medical Technologies Corporation NMTC
0.75 USD -0.06 (-6.85%)
At closeNov 12, 2026, 5:47 PM EST
0.71 -0.04 -4.84%
After hours · Nov 12, 5:47 PM ET
0.745 Day range 0.8399
0.7474 52-week range 5.89
- YTD
- -83.57%
- 1 year
- -83.01%
News
benzinga.com NeuroOne Medical Technologies Publishes Initial Clinical Results For Its OneRF Trigeminal Nerve Ablation System NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on the surgical diagnosis and treatment of neurological disorders, today
globenewswire.com NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System Study Reports Immediate Pain Freedom in 14 of 15 Patients; all Patients Achieved Favorable Pain Outcomes at a Mean Six-Month Follow-Up Multi-Contact Probe Technology Enabled Mapping and Treatment of…
globenewswire.com NeuroOne Featured in New York Post on OneRF® Patient's Remarkable Journey to Overcome Debilitating Facial Pain NeuroOne's FDA 510(k)-Cleared OneRF Trigeminal Nerve Ablation System Offers Hope for Patients Suffering from Trigeminal Neuralgia EDEN PRAIRIE, Minn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NeuroOne…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's after-market session. The company's market cap stands at $67.1 million. Aardvark Therapeutics…
benzinga.com NeuroOne Secures First Pharmaceutical Industry Purchase Order For StereoCED Drug Delivery Platform; No Terms Disclosed Major Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical CompaniesEDEN PRAIRIE, Minn., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeuroOne…
globenewswire.com NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Research
defenseworld.net NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Stock Short Interest Climbs 135.8% NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
globenewswire.com NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…
defenseworld.net NeuroOne (NASDAQ: NMTC) secures a $4.5M order as revenue climbs again What happened NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) said preliminary fourth-quarter product revenue was $3.8 million. That was up 38.4% from $2.7 million a year earlier. The…
benzinga.com NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological
globenewswire.com NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance Range EDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE…
defenseworld.net Innovative Eyewear (NASDAQ:LUCY) and NeuroOne Medical Technologies (NASDAQ:NMTC) Head-To-Head Review NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) and Innovative Eyewear (NASDAQ: LUCY - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We…
gurufocus.com $10 Million in New Markets Tax Credit Financing for a New cold Storage and Refrigerated Logistics Facility in Albertville, AL $10 Million in New Markets Tax Credit Financing for a New cold Storage and Refrigerated Logistics Facility in Albertville, ALPR NewswireATMORE, Ala., Oct. 2, 20
defenseworld.net Analysts Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Price Target at $7.33 Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the…
globenewswire.com NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming…- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million. Picard Medical (AMEX:PMI) stock moved…
benzinga.com NeuroOne Completes Three Large-Animal StereoCED Procedures, Including Combined Drug Delivery And Brain Recording; Builds Momentum Toward Planned Launch Of The StereoCED Platform For Human Investigational Clinical Studies Later This Quarter Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED™ Revenue Expected to…
gurufocus.com $6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL $6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL- benzinga.com Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5 Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.
seekingalpha.com NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com NeuroOne Medical Tech Q2 2026 Earnings Call Transcript
seekingalpha.com NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
benzinga.com NeuroOne Medical Tech Q2 EPS $(0.25) Misses $(0.23) Estimate, Sales $2.391M Miss $2.576M Estimate NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 40.48 percent increase over losses…
benzinga.com Earnings Scheduled For May 12, 2026 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
defenseworld.net Analyzing First Choice Healthcare Solutions (OTCMKTS:FCHS) & NeuroOne Medical Technologies (NASDAQ:NMTC) First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior…
seekingalpha.com NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
defenseworld.net Brokerages Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) PT at $1.98 Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the firm,…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
- benzinga.com Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5 Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.
seekingalpha.com NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
benzinga.com Insights into NeuroOne Medical Tech Q1 Earnings - benzinga.com NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 150 percent decrease over earnings of…
- benzinga.com Earnings Scheduled For February 17, 2026
benzinga.com What to Expect from NeuroOne Medical Tech's Earnings 
defenseworld.net NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the…
defenseworld.net Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Cannlabs (OTCMKTS:CANL) Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 63.64 percent increase over losses of $(0.11) per share from the…
benzinga.com NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results: ●Achieved annual total product revenue of- benzinga.com Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3 Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.
- benzinga.com NeuroOne Medical Tech Affirms FY2025 Sales Guidance of $8.00M-$10.00M vs $8.71M Est NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million vs $8.71 million estimate.
benzinga.com NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 70 percent increase over losses of…
benzinga.com Earnings Scheduled For August 14, 2025 - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session